According to a press release late Friday night, the FDA has approved the Pfizer-BioNTech vaccine for distribution and use on patients 16 years old and older, and wants to do so as soon as possible. The New York Times reports that the company has an agreement with the United States Government to “supply 100 million doses of the vaccine by next March. Under that agreement, the shots will be free to the public.” (New York Times)